Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Armin Buschauer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Physiology

Competitive Binding

Genes & Molecular Sequences

Molecular Structure

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
35
Bernhardt, Günther
17
Seifert, Roland
16
Dove, Stefan
8
Elz, Sigurd
8
Spruss, Thilo
7
Ghorai, Prasanta
7
Kraus, Anja
6
Schneider, Erich
4
Xie, Sheng-Xue
4
Ye, Qi-Zhuang
4
Hoechstetter, Julia
3
Gross, Dietmar
3
Bernhardt, Günther
3
Braun, Stephan
3
Ziemek, Ralf

Sign-in to see all Coauthors

Publications

TOP 3
Igel Patrick; Geyer Roland; Strasser Andrea; Dove Stefan; Seifert Roland; Buschauer Armin
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
Keller Max; Teng Shangjun; Bernhardt Günther; Buschauer Armin
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
Igel Patrick; Schneider Erich; Schnell David; Elz Sigurd; Seifert Roland; Buschauer Armin
N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Armin Buschauer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Igel Patrick; Geyer Roland; Strasser Andrea; Dove Stefan; Seifert Roland; Buschauer Armin
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
Journal of medicinal chemistry 2009;52(20):6297-313.
2009: Keller Max; Teng Shangjun; Bernhardt Günther; Buschauer Armin
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
ChemMedChem 2009;4(10):1733-45.
2009: Igel Patrick; Schneider Erich; Schnell David; Elz Sigurd; Seifert Roland; Buschauer Armin
N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.
Journal of medicinal chemistry 2009;52(8):2623-7.
2009: Kühnle Matthias; Egger Michael; Müller Christine; Mahringer Anne; Bernhardt Günther; Fricker Gert; König Burkhard; Buschauer Armin
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
Journal of medicinal chemistry 2009;52(4):1190-7.
2009: Igel Patrick; Schnell David; Bernhardt Günther; Seifert Roland; Buschauer Armin
Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
ChemMedChem 2009;4(2):225-31.
2009: Kraus Anja; Ghorai Prasanta; Birnkammer Tobias; Schnell David; Elz Sigurd; Seifert Roland; Dove Stefan; Bernhardt Günther; Buschauer Armin
N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.
ChemMedChem 2009;4(2):232-40.
2008: Ghorai Prasanta; Kraus Anja; Keller Max; Götte Carsten; Igel Patrick; Schneider Erich; Schnell David; Bernhardt Günther; Dove Stefan; Zabel Manfred; Elz Sigurd; Seifert Roland; Buschauer Armin
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
Journal of medicinal chemistry 2008;51(22):7193-204.
2008: Weiss Stefan; Keller Max; Bernhardt Günther; Buschauer Armin; König Burkhard
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
Bioorganic & medicinal chemistry 2008;16(22):9858-66.
2008: Dove Stefan; Seifert Roland; Elz Sigurd; Buschauer Armin
Frontiers in medicinal chemistry in Regensburg.
ChemMedChem 2008;3(8):1181-4.
2008: Hubensack Martina; Müller Christine; Höcherl Peter; Fellner Stephan; Spruss Thilo; Bernhardt Günther; Buschauer Armin
Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice.
Journal of cancer research and clinical oncology 2008;134(5):597-607.
2008: Hofinger Edith S A; Hoechstetter Julia; Oettl Martin; Bernhardt Günther; Buschauer Armin
Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases.
Glycoconjugate journal 2008;25(2):101-9.
2007: Preuss Hendrik; Ghorai Prasanta; Kraus Anja; Dove Stefan; Buschauer Armin; Seifert Roland
Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.
Naunyn-Schmiedeberg's archives of pharmacology 2007;376(4):253-64.
2007: Schneider Erich; Keller Max; Brennauer Albert; Hoefelschweiger Bianca K; Gross Dietmar; Wolfbeis Otto S; Bernhardt Günther; Buschauer Armin
Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist.
Chembiochem : a European journal of chemical biology 2007;8(16):1981-8.
2007: Hofinger Edith S A; Bernhardt Günther; Buschauer Armin
Kinetics of Hyal-1 and PH-20 hyaluronidases: comparison of minimal substrates and analysis of the transglycosylation reaction.
Glycobiology 2007;17(9):963-71.
2007: Preuss Hendrik; Ghorai Prasanta; Kraus Anja; Dove Stefan; Buschauer Armin; Seifert Roland
Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
The Journal of pharmacology and experimental therapeutics 2007;321(3):975-82.
2007: Preuss Hendrik; Ghorai Prasanta; Kraus Anja; Dove Stefan; Buschauer Armin; Seifert Roland
Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
The Journal of pharmacology and experimental therapeutics 2007;321(3):983-95.
2007: Hofinger Edith S A; Spickenreither Martin; Oschmann Jan; Bernhardt Günther; Rudolph Rainer; Buschauer Armin
Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors.
Glycobiology 2007;17(4):444-53.
2007: Müller Christine; Gross Dietmar; Sarli Vasiliki; Gartner Michael; Giannis Athanassios; Bernhardt Günther; Buschauer Armin
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Cancer chemotherapy and pharmacology 2007;59(2):157-64.
2007: Xie Sheng-Xue; Schalkhausser Fabian; Ye Qi-Zhuang; Seifert Roland; Buschauer Armin
Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Archiv der Pharmazie 2007;340(1):9-16.
2007: Ziemek Ralf; Schneider Erich; Kraus Anja; Cabrele Chiara; Beck-Sickinger Annette G; Bernhardt Günther; Buschauer Armin
Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence.
Journal of receptor and signal transduction research 2007;27(4):217-33.
2006: Ziemek Ralf; Brennauer Albert; Schneider Erich; Cabrele Chiara; Beck-Sickinger Annette G; Bernhardt Günther; Buschauer Armin
Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
European journal of pharmacology 2006;551(1-3):10-8.
2006: Spickenreither Martin; Braun Stephan; Bernhardt Günther; Dove Stefan; Buschauer Armin
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
Bioorganic & medicinal chemistry letters 2006;16(20):5313-6.
2006: Schneider Erich; Mayer Matthias; Ziemek Ralf; Li Liantao; Hutzler Christoph; Bernhardt Günther; Buschauer Armin
A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
Chembiochem : a European journal of chemical biology 2006;7(9):1400-9.
2006: Gross Dietmar; Bernhardt Günther; Buschauer Armin
Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.
Journal of cancer research and clinical oncology 2006;132(9):589-99.
2006: Xie Sheng-Xue; Petrache Georgiana; Schneider Erich; Ye Qi-Zhuang; Bernhardt Günther; Seifert Roland; Buschauer Armin
Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.
Bioorganic & medicinal chemistry letters 2006;16(15):3886-90.
2006: Rigden Daniel J; Botzki Alexander; Nukui Masatoshi; Mewbourne R Brandon; Lamani Ejvis; Braun Stephan; von Angerer Erwin; Bernhardt Günther; Dove Stefan; Buschauer Armin; Jedrzejas Mark J
Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
Glycobiology 2006;16(8):757-65.
2006: Xie Sheng-Xue; Kraus Anja; Ghorai Prasanta; Ye Qi-Zhuang; Elz Sigurd; Buschauer Armin; Seifert Roland
N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
The Journal of pharmacology and experimental therapeutics 2006;317(3):1262-8.
2006: Xie Sheng-Xue; Ghorai Prasanta; Ye Qi-Zhuang; Buschauer Armin; Seifert Roland
Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
The Journal of pharmacology and experimental therapeutics 2006;317(1):139-46.
2005: Salmen Sunnhild; Hoechstetter Julia; Käsbauer Christian; Paper Dieter H; Bernhardt Günther; Buschauer Armin
Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae.
Planta medica 2005;71(8):727-32.
2004: Gürtler Ulrich; Fuchs Peter; Stangelmayer Achim; Bernhardt Günther; Buschauer Armin; Spruss Thilo
Construction and validation of a microprocessor controlled extracorporal circuit in rats for the optimization of isolated limb perfusion.
Archiv der Pharmazie 2004;337(12):672-81.
2004: Dove Stefan; Elz Sigurd; Seifert Roland; Buschauer Armin
Structure-activity relationships of histamine H2 receptor ligands.
Mini reviews in medicinal chemistry 2004;4(9):941-54.
2004: Botzki Alexander; Rigden Daniel J; Braun Stephan; Nukui Masatoshi; Salmen Sunnhild; Hoechstetter Julia; Bernhardt Günther; Dove Stefan; Jedrzejas Mark J; Buschauer Armin
L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes.
The Journal of biological chemistry 2004;279(44):45990-7.
2004: Kiessling Stephan; Muller-Newen Gerhard; Leeb Sandra N; Hausmann Martin; Rath Heiko C; Strater Jorn; Spottl Tanja; Schlottmann Klaus; Grossmann Johannes; Montero-Julian F A; Scholmerich Jurgen; Andus Tilo; Buschauer Armin; Heinrich Peter C; Rogler Gerhard
Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.
The Journal of biological chemistry 2004;279(11):10304-15.
2003: Li Liantao; Mayer Matthias; Schneider Erich; Schreiber Elvira; Bernhardt Günther; Peng Shiqi; Buschauer Armin
Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A.
Archiv der Pharmazie 2003;336(12):585-90.
2003: Parker Steven L; Parker Michael S; Buschauer Armin; Balasubramaniam Ambikaipakan
Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides.
European journal of pharmacology 2003;474(1):31-42.
2003: Seifert Roland; Wenzel-Seifert Katharina; Burckstummer Tilmann; Pertz Heinz H; Schunack Walter; Dove Stefan; Buschauer Armin; Elz Sigurd
Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
The Journal of pharmacology and experimental therapeutics 2003;305(3):1104-15.
2003: Li Liantao; Kracht Julia; Peng Shiqi; Bernhardt Günther; Elz Sigurd; Buschauer Armin
Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine.
Bioorganic & medicinal chemistry letters 2003;13(10):1717-20.
2003: Li Liantao; Kracht Julia; Peng Shiqi; Bernhardt Günther; Buschauer Armin
Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.
Bioorganic & medicinal chemistry letters 2003;13(7):1245-8.
2003: Oettl Martin; Hoechstetter Julia; Asen Iris; Bernhardt Günther; Buschauer Armin
Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;18(3-4):267-77.
2002: Fellner Stephan; Bauer Björn; Miller David S; Schaffrik Martina; Fankhänel Martina; Spruss Thilo; Bernhardt Günther; Graeff Claudia; Färber Lothar; Gschaidmeier Harald; Buschauer Armin; Fricker Gert
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.
The Journal of clinical investigation 2002;110(9):1309-18.
2002: Weiss Thomas S; Bernhardt Günther; Buschauer Armin; Thasler Wolfgang E; Dolgner Doris; Zirngibl Hubert; Jauch Karl-Walter
Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
International journal of colorectal disease 2002;17(6):381-7.
2002: Parker S L; Parker M S; Lundell I; Balasubramaniam A; Buschauer A; Kane J K; Yalcin A; Berglund M M
Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling.
Regulatory peptides 2002;107(1-3):49-62.
2002: Vogelhuber W; Spruss T; Bernhardt G; Buschauer A; Göpferich A
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts.
International journal of pharmaceutics 2002;238(1-2):111-21.
2001: Kelley M T; Bürckstümmer T; Wenzel-Seifert K; Dove S; Buschauer A; Seifert R
Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.
Molecular pharmacology 2001;60(6):1210-25.
2001: Wenzel-Seifert K; Kelley M T; Buschauer A; Seifert R
Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha).
The Journal of pharmacology and experimental therapeutics 2001;299(3):1013-20.
2001: Schuster A; Götte C; Bernhardt G; Buschauer A
Chiral separation of pheniramine-like 3-phenyl-3-heteroarylpropylamines by CE and HPLC methods.
Chirality 2001;13(6):285-93.
2001: Vogelhuber W; Rotunno P; Magni E; Gazzaniga A; Spruss T; Bernhardt G; Buschauer A; Göpferich A
Programmable biodegradable implants.
Journal of controlled release : official journal of the Controlled Release Society 2001;73(1):75-88.
2000: Aiglstorfer I; Hendrich I; Moser C; Bernhardt G; Dove S; Buschauer A
Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.
Bioorganic & medicinal chemistry letters 2000;10(14):1597-600.
2000: Zabel M; Breu J; Rau F; Range K J; Krey V; Uffrecht A; Buschauer A
Absolute configuration of (-)-4-(3,4-dichlorophenyl)-4-(2-pyridyl)butanoic acid: essential information to determine crucial steric features of arpromidine-type histamine H2 receptor agonists.
Acta crystallographica. Section C, Crystal structure communications 2000;56 ( Pt 2)():250-1.
2000: Moser C; Bernhardt G; Michel J; Schwarz H; Buschauer A
Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.
Canadian journal of physiology and pharmacology 2000;78(2):134-42.
2000: Dove S; Michel M C; Knieps S; Buschauer A
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists.
Canadian journal of physiology and pharmacology 2000;78(2):108-15.
1999: Meister A; Bernhardt G; Christoffel V; Buschauer A
Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: discrimination between drug and ethanol effects.
Planta medica 1999;65(6):512-6.
1998: Muckenschnabel I; Bernhardt G; Spruss T; Buschauer A
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy.
Cancer letters 1998;131(1):71-84.
1998: Muckenschnabel I; Bernhardt G; Spruss T; Dietl B; Buschauer A
Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers.
Cancer letters 1998;131(1):13-20.
1998: Aiglstorfer I; Uffrecht A; Gessele K; Moser C; Schuster A; Merz S; Malawska B; Bernhardt G; Dove S; Buschauer A
NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures.
Regulatory peptides 1998;75-76():9-21.
1998: Dove S; Buschauer A
Imidazolylpropylguanidines as histamine H2 receptor agonists:3D-QSAR of a large series.
Pharmaceutica acta Helvetiae 1998;73(3):145-55.
1997: Müller M; Knieps S; Gessele K; Dove S; Bernhardt G; Buschauer A
Synthesis and neuropeptide Y Y1 receptor antagonistic activity of N,N-disubstituted omega-guanidino- and omega-aminoalkanoic acid amides.
Archiv der Pharmazie 1997;330(11):333-42.
1997: Weiss T; Bernhardt G; Buschauer A; Jauch K W; Zirngibl H
High-resolution reversed-phase high-performance liquid chromatography analysis of polyamines and their monoacetyl conjugates by fluorescence detection after derivatization with N-hydroxysuccinimidyl 6-quinolinyl carbamate.
Analytical biochemistry 1997;247(2):294-304.
1996: Muckenschnabel I; Bernhardt G; Spruss T; Buschauer A
Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice.
Cancer chemotherapy and pharmacology 1996;38(1):88-94.
1995: Glass D; Buschauer A; Tenor H; Bartel S; Will-Shahab L; Krause E G
4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activity.
Archiv der Pharmazie 1995;328(10):709-19.
1995: Buschauer A; Mohr R; Schunack W
Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Archiv der Pharmazie 1995;328(4):349-58.
1992: Buschauer A; Lachenmayr F; Schunack W
Synthesis and histamine H2-receptor activity of heterocyclic impromidine analogues.
Die Pharmazie 1992;47(2):86-91.
1991: Buschauer A; Lachenmayr F; Schunack W
Synthesis and histamine H2-agonistic activity of ring-substituted phenyl analogues of impromidine.
Die Pharmazie 1991;46(12):840-5.
1990: Meindl W; Friese-Kimmel A; Lachenmayr F; Buschauer A; Schunack W
[The effect of agonists and antagonists of histamine H1- and H2-receptors on the growth of Mycobacterium tuberculosis H 37 Ra]
Archiv der Pharmazie 1990;323(5):267-72.
1987: Buschauer A
[Synthesis and pharmacologic action of arylmethylethylguanidines]
Arzneimittel-Forschung 1987;37(9):1008-12.
1987: Buschauer A
[Synthesis and pharmacologic action of substituted imidazolyl- and thiazolylmethylthioethylguanidine]
Arzneimittel-Forschung 1987;37(9):1003-7.

Sign-in to see more